Table 1.

Engraftment of CD34+ Cells in Animals Preinjected With Irradiated CD34 Cells and in Splenectomized Animals as Compared to Controls

Experiment-150Input % CD45-151 BM % CD45-151 Spleen% CD45-151 PB
I  CD34 <1.0 <1.0  <1.0  
 CD34+ 18.2 ± 11.2 8.5 ± 4.7  3.7 ± 2.0  
 CD34 and CD34+ 14.8 ± 4.1  13.5 ± 1.9 2.6 ± 0.2  
II  CD34+ 26.3 ± 1.2 nd  nd  
 CD34+ Spl-X 19.4 ± 15.4  —  nd 
Experiment-150Input % CD45-151 BM % CD45-151 Spleen% CD45-151 PB
I  CD34 <1.0 <1.0  <1.0  
 CD34+ 18.2 ± 11.2 8.5 ± 4.7  3.7 ± 2.0  
 CD34 and CD34+ 14.8 ± 4.1  13.5 ± 1.9 2.6 ± 0.2  
II  CD34+ 26.3 ± 1.2 nd  nd  
 CD34+ Spl-X 19.4 ± 15.4  —  nd 

Abbreviations: BM, bone marrow; PB, peripheral blood; nd, not done.

F0-150

Two independent experiments in which sublethally irradiated NOD/SCID mice were injected with CD34+ cells from a G-CSF–mobilized apheresis product. In experiment I, animals were either injected with 20 Gy irradiated monocyte-depleted (by plastic adherence for 30 minutes at 37°C) CD34 cells (25 × 106 per animal) alone, with CD34+ cells alone (9 × 106 per animal), or with CD34 cells followed by CD34+ cells four hours later (n = 2 per group). In experiment II, 12 × 106 CD34+cells were injected in splenectomized or nonsplenectomized animals (n = 2 per group).

F0-151

Percentage human cells was determined by flow cytometry using an antibody specific for human CD45.

Close Modal

or Create an Account

Close Modal
Close Modal